captopril has been researched along with omapatrilat in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 11 (78.57) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Abrego, V; Angeles, E; Balboa, MA; Camacho, B; Díaz-Barriga, S; López-Castañares, R; Martínez, L; Romero, A; Torres, LA; Velázquez, AM | 1 |
Codd, R; Gotsbacher, MP; Roth, L | 1 |
Asaad, MM; Fox, M; Monticello, TM; Panchal, BC; Trippodo, NC | 1 |
Banerjee, T; Clark, AL; Cleland, JG; Thackray, S; Witte, K | 1 |
d'Uscio, LV; Lüscher, TF; Quaschning, T; Shaw, S | 1 |
d'Uscio, LV; Lüscher, TF; Quaschning, T; Ruschitzka, FT; Shaw, S; Viswambharan, H | 1 |
D'Uscio, LV; Gröne, HJ; Lüscher, TF; Quaschning, T; Ruschitzka, F; Shaw, S | 1 |
Bäcklund, T; Eriksson, A; Grönholm, T; Laine, M; Palojoki, E; Tikkanen, I; Vuolteenaho, O | 1 |
Adam, A; Bachvarov, DR; Blais, C; Clément, R; Lapointe, N; Rouleau, JL | 1 |
Adam, A; Blais, C; Clément, R; Gosselin, H; Lapointe, N; Parker, T; Rouleau, JL; Sirois, MG | 1 |
Boffa, JJ; Chansel, D; Chatziantoniou, C; Dussaule, JC; Flamant, M; Vandermeersch, S; Ying, L | 1 |
Adam, A; Blais, C; Clément, R; Deschepper, CE; Lapointe, N; Parker, TG; Rouleau, D; Rouleau, JL; Slaughter, G; Tsoporis, JN | 1 |
Baxter, GF; Ebrahim, Z; Yellon, DM | 1 |
Berry, C; Biggerstaff, F; Clarke, A; Dalzell, JR; Hillier, C; McMurray, JJ; Padmanabhan, N; Petrie, MC; Seed, A; Whelan, CJ | 1 |
14 other study(ies) available for captopril and omapatrilat
Article | Year |
---|---|
Synthesis and antihypertensive effects of new methylthiomorpholinphenol derivatives.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Design; Heart Rate; Morpholines; Phenols; Rats | 2008 |
Immobilized Metal Affinity Chromatography as a Drug Discovery Platform for Metalloenzyme Inhibitors.
Topics: Chromatography, Affinity; Coordination Complexes; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Humans; Imino Acids; Metalloproteins; Metals, Heavy; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2020 |
Vasopeptidase inhibition with omapatrilat improves cardiac geometry and survival in cardiomyopathic hamsters more than does ACE inhibition with captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Captopril; Cardiomyopathy, Dilated; Cricetinae; Hemodynamics; Male; Myocardium; Protease Inhibitors; Pyridines; Survival Analysis; Thiazepines | 1999 |
Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Exercise Tolerance; Heart Failure; Humans; Losartan; Pyridines; Randomized Controlled Trials as Topic; Thiazepines | 2000 |
Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Captopril; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Male; Neprilysin; Nitrates; Nitric Oxide Synthase; Nitrites; Pyridines; Regression Analysis; Renal Artery; Sodium, Dietary; Statistics, Nonparametric; Thiazepines; Vasoconstriction; Vasodilation | 2001 |
Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Endothelin-1; Endothelins; Enzyme Inhibitors; Hypertension; Male; Metalloendopeptidases; Neprilysin; Protein Precursors; Pyridines; Rats; Rats, Inbred Dahl; Renal Artery; Sodium, Dietary; Thiazepines | 2001 |
Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Vessels; Captopril; Cardiomegaly; Endothelium, Vascular; Hypertension; Hypertrophy; Kidney Glomerulus; Male; Myocardium; Neprilysin; Protease Inhibitors; Pyridines; Rats; Rats, Inbred Dahl; Renal Circulation; Sodium Chloride; Thiazepines; Vasoconstriction; Vasodilation | 2001 |
Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Heart; Kidney; Male; Myocardium; Natriuretic Agents; Natriuretic Peptide, Brain; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Wistar; Thiazepines | 2001 |
Effects of captopril and omapatrilat on early post-myocardial infarction survival and cardiac hemodynamics in rats: interaction with cardiac cytokine expression.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Captopril; Coronary Circulation; Cytokines; Heart; Hemodynamics; Interleukin-10; Male; Myocardial Infarction; Myocardium; Pyridines; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazepines; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2002 |
Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Hemodynamics; Male; Myocardial Infarction; Myocardium; Neurotransmitter Agents; Protease Inhibitors; Pyridines; Rats; Rats, Wistar; Thiazepines; Treatment Outcome; Ventricular Remodeling | 2002 |
Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood Vessels; Captopril; Cyclic GMP; Endothelin-1; Enzyme Inhibitors; Fibrosis; Hypertension, Renal; Kidney; Male; Neprilysin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Protease Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Sodium Chloride; Survival Rate; Thiazepines | 2003 |
Comparative effects of a vasopeptidase inhibitor vs. an angiotensin converting enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Captopril; Cells, Cultured; DNA; Electrophoresis, Agar Gel; Enzyme Inhibitors; Fibrosis; Heart Failure; Hemodynamics; Hydrogen Peroxide; Inhibitory Concentration 50; Male; Myocytes, Cardiac; Protease Inhibitors; Pyridines; Rats; Rats, Wistar; Thiazepines; Time Factors | 2003 |
Omapatrilat limits infarct size and lowers the threshold for induction of myocardial preconditioning through a bradykinin receptor-mediated mechanism.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Captopril; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Organ Size; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Thiazepines | 2004 |
Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat.
Topics: Adrenomedullin; Aged; Angiotensin I; Arteries; Captopril; Female; Humans; Male; Middle Aged; Neprilysin; Protease Inhibitors; Pyridines; Substance P; Thiazepines; Thiorphan; Vasodilation | 2014 |